Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Victoria Lane Thomas, M.D.

Concepts (54)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Civil Rights120091320.340 Why?
Adrenergic beta-2 Receptor Agonists32016990.310 Why?
Physician's Role120099690.220 Why?
Particle Size2201616900.210 Why?
Disabled Persons1200911040.190 Why?
Adrenal Cortex Hormones3201617900.170 Why?
Anti-Asthmatic Agents220165300.140 Why?
Asthma3201656970.120 Why?
Microspheres120157840.120 Why?
Health Services Accessibility1200948570.110 Why?
Adrenergic beta-Antagonists1201612330.100 Why?
Administration, Inhalation3201610960.090 Why?
Supreme Court Decisions120091210.080 Why?
Glucocorticoids1201520560.070 Why?
Prejudice120095700.070 Why?
Stroke Volume1201642410.060 Why?
Heart Failure2201694650.060 Why?
Pulmonary Disease, Chronic Obstructive1201628900.060 Why?
Disability Evaluation1200918010.050 Why?
Beclomethasone12016430.040 Why?
Pregnenediones12016290.040 Why?
Databases, Factual3201675650.040 Why?
Muscarinic Antagonists120161280.040 Why?
Drug Utilization Review120162560.040 Why?
Drug Therapy, Combination2201665180.030 Why?
Drug Dosage Calculations120151140.030 Why?
Polypharmacy120162560.030 Why?
Bronchodilator Agents120164990.030 Why?
Netherlands1201620610.030 Why?
Delayed-Action Preparations120159700.030 Why?
Angiotensin Receptor Antagonists120167530.030 Why?
Comparative Effectiveness Research120156580.020 Why?
Angiotensin-Converting Enzyme Inhibitors1201614360.020 Why?
Cohort Studies32016385480.020 Why?
Guideline Adherence1201622970.020 Why?
Dose-Response Relationship, Drug12015112720.010 Why?
United States12009654030.010 Why?
Logistic Models12016134160.010 Why?
Primary Health Care1201643820.010 Why?
Treatment Outcome22016602000.010 Why?
Humans520166858840.010 Why?
Practice Guidelines as Topic1201674400.010 Why?
Disease Progression12015130160.010 Why?
Male420163452990.010 Why?
Female420163687810.010 Why?
Time Factors12016408170.010 Why?
Follow-Up Studies12015388340.010 Why?
Child, Preschool12015404380.010 Why?
Adult220162078470.010 Why?
Middle Aged220162117470.010 Why?
Aged, 80 and over12016577780.010 Why?
Retrospective Studies12016680430.010 Why?
Child12015716170.010 Why?
Aged120161594750.000 Why?
Thomas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.